A rare case of type i glutaric aciduria in an early child

Glutaric aciduria type I (deficiency of glutaryl-COA dehydrogenase, glutaric acidemia type I) is a rare autosomal recessive disease caused by mutations in the gene encoding the enzyme glutaryl – COA - dehydrogenase (GCDH). Cerebral organic aciduria, caused by a deficiency of glutaryl-COA - dehydrogenase, is generally considered a neurological disorder.

The phenotypic spectrum of untreated GA-1 varies from a more common and pronounced form (a disease with infancy) to a low-symptom and less common form. In people with the same genotype, the clinical manifestations and depth of CNS damage can vary widely depending on the age of manifestation of acute encephalopathic crises. It is assumed that with early detection and treatment of “asymptomatic” newborns (in the context of screening for this disease), most people who would have developed manifestations of GA-1 with childhood or late onset will remain asymptomatic. 

1. Herskovitz M., Goldsher D., Sela B.A., Mandel H. Subependymal mass lesions and peripheral polyneuropathy in adult‐onset glutaric aciduria type. I Neurology. 2013;81:849-850. doi: 10.1212/WNL.0b013e3182a2cbf2.

2. Kölker S., Valayannopoulos V., Burlina A.B., Sykut-Cegielska J., Wijburg F.A. et al. The phenotypic spectrum of organic acidurias and urea cycle disorders. Part 2: the evolving clinical phenotype. J Inherit Metab Dis. 2015;38:1059–1074. https://doi.org/10.1007/s10545-015-9840-x.

3. Mikhailova S.V., Zakharova E.Yu., Petrukhin A.S. Neirometabolicheskie zabolevaniya u detei i podrostkov. Diagnostika i podkhody k lecheniyu. Moscow: Literra;2019. (In Russ.)

4. Tokareva YuV, Kotov AS, Sidorova OP. Genetically confirmed l-2-hydroxyglutaric aciduria. Nevrologicheskii zhurnal. 2017;22(1):45-49. (In Russ.) doi: 10.18821/1560-9545-2017-22-1-45-49.

5. Boy N, Mengler K, Thimm E, Schiergens KA, Marquardt T. et al. Newborn screening: a disease-changing intervention for glutaric aciduria type 1. Ann Neurol. 2018;83:970–979. doi: 10.1002/ana.25233.

6. Boy N, Mühlhausen C, Maier EM, Heringer J, Assmann B. et al. Proposed recommendations for diagnosing and managing individuals with glutaric aciduria type I: second revision. J Inherit Metab Dis. 2017;40:75-101. doi: 10.1007/s10545-016-9999-9.

7. Tsai FC, Lee HJ, Wang AG, Hsieh SC, Lu YH. et al. Experiences during newborn screening for glutaric aciduria type 1: diagnosis, treatment, genotype, phenotype, and outcomes. J Chin Med Assoc. 2017;80:253-261. doi: 10.1016/j.jcma.2016.07.006.

8. Mikhailova SV, Zakharova EYu, Bobylova MYu, Il'ina ES, Banin AV. et al. Glutaric aciduria type 1: clinical presentations, diagnostics and treatment. Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova. 2007;107(10):4-12. (In Russ.). eLIBRARY ID: 9597007

9. Kölker S, Garcia-Cazorla A, Valayannopoulos V, Lund AM, Burlina AB. et al. The phenotypic spectrum of organic acidurias and urea cycle disorders. Part 1: the initial presentation. J Inherit Metab Dis. 2015;38:1041-1057. doi: 10.1007/s10545-015-9839-3

10. Boy N, Heringer J, Brackmann R, Bodamer O, Seitz A. et al. Extrastriatal changes in patients with late-onset glutaric aciduria type I highlight the risk of long-term neurotoxicity. Orphanet J Rare Dis. 2017;12:77. doi: 10.1186/s13023-017-0612-6.

11. Harting I, Boy N, Heringer J, Seitz A, Bendszus M. et al H‐MRS in glutaric aciduria type 1: Impact of biochemical phenotype and age on the cerebral accumulation of neurotoxic metabolites. J Inherit Metab Dis. 2015;38:829-838. https://doi.org/10.1007/s10545-015-9826-8.

12. Baranov AA, Namazova-Baranova LS, Borovik TE, Bushueva TV, Globa OV. et al. Glutarovaya atsiduriya tip I u detei. Klinicheskie rekomendatsii soyuza pediatrov Rossii. Moscow, 2017. (In Russ.). https://med-gen.ru/docs/recomend-aciduriya.pdf. Accessed April 26, 2020.

13. Kranendijk M, Struys EA, Salomons GS, Van der Knaap MS, Jakobs C. Progress in understanding 2-hydroxyglutaric acidurias. J. Inherit. Metab. Dis. 2012;35(4):571-587. doi: 10.1007/s10545-012-9462-5.

14. Steenweg ME, Jakobs C, Errami A, van Dooren SJ, Adeva Bartolomé MT, Aerssens P. et al. An overview of L-2-hydroxyglutarate dehydrogenase gene (L2HGDH) variants: a genotype-phenotype study. Hum. Mutat. 2010;31(4):380-390. doi: 10.1002 / humu.21197.

15. Mohammad SA, Abdelkhalek HS, Ahmed KA, Zaki OK. Glutaric aciduria type 1: neuroimaging features with clinical correlation. Pediatr Radiol. 2015;45:1696-1705. https://doi.org/10.1007/s00247-015-3395-8.

16. Boy N, Mühlhausen C, Maier EM, Heringer J, Assmann B. et al. Additional individual contributors. Proposed recommendations for diagnosing and managing individuals with glutaric aciduria type I: second revision. J Inherit Metab Dis. 2017;40(1):75-101. doi: 10.1007/s10545-016-9999-9.

17. Larson A, Goodman S. Glutaric Acidemia Type 1. 2019 Sep 19. In: Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® University of Washington, Seattle; 1993-2020. PMID: 31536184.

18. Peters V, Morath M, Mack M, Liesert M, Buckel W. et al. Formation of 3-hydroxyglutaric acid in glutaric aciduria type I: in vitro participation of medium chain acyl-CoA dehydrogenase. JIMD Rep. 2019;47(1):30-34. doi: 10.1002/jmd2.12026.